Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung.
Thrombin-generated cleavage sites of human fibrinogen have been identified adjacent to viable tumor cells in fresh frozen sections of small cell carcinoma of the lung (SCCL) by means of immunohistochemical techniques using mouse monoclonal antibodies to the N-terminal peptides of the fibrinogen alpha and beta chains. These results indicate that thrombin is generated in situ in this tumor type. Based on previous evidence for the existence of an initiator of coagulation together with coagulation factor intermediates associated with viable SCCL tumor cells in situ, and also for the favorable effects of anticoagulant therapy with warfarin in SCCL, we postulate that local tumor cell-induced thrombin formation may contribute to self-regulated progression of SCCL through deposition of fibrin and stimulation of cell proliferation. These results suggest novel treatment strategies for this particular tumor type and justify efforts to identify other tumor types in which similar mechanisms exist.
Zacharski
L R
LR
Department of Medicine, Dartmouth Medical School, Hanover, New Hampshire.
Memoli
V A
VA
Rousseau
S M
SM
D000911:Antibodies, Monoclonal; D018288:Carcinoma, Small Cell / Q000378:metabolism*; D005337:Fibrin / Q000032:analysis*; D005340:Fibrinogen / Q000378:metabolism*; D006801:Humans; D007124:Immunoenzyme Techniques; D008175:Lung Neoplasms / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D005337:Fibrin; D005340:Fibrinogen